Jeffrey Dierks, CHIEF COMMERCIAL OFFICER at Harmony Biosciences Holdings, Inc. (HRMY), sold 9,238 shares at $32.61 ($302K) on 2025-03-03, disclosed to the SEC on 2025-03-05.
Scheduled sale ($302k) by CHIEF COMMERCIAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.61 | 4,369 | $142K | 47.2% |
| 2 | $32.61 | 4,369 | $142K | 47.2% |
| 3 | $33.23 | 500 | $17K | 5.5% |
| Total | $32.64 avg | 9,238 | $302K | 100% |
| Filing → |
| HRMY | SELL | 2025-01-16 | $778K | — | Filing → |
| HRMY | SELL | 2025-01-15 | $532K | — | Filing → |
| HRMY | SELL | 2024-10-31 | $1.7M | — | Filing → |